Skip to Main Content

Paper Details

TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR Metastatic Triple-Negative Breast Cancer.
Clinical Cancer Research
80
2020
Author NameAffiliation
Melinda E SandersVanderbilt University
Melinda E SandersVanderbilt University Medical Center
Rita NandaUniversity of Chicago
Anna Maria StornioloIndiana University
Julie NangiaBaylor College of Medicine
Paula I Gonzalez-EricssonVanderbilt University
Paula I Gonzalez-EricssonVanderbilt University Medical Center
Antonio C WolffJohns Hopkins School of Medicine
  • 1 - 8

Datasets

Release 1.2